Medicare Procedure and Patient Information
2019 Medicare Patient Data
Information about Medicare patients treated by Dr. Philip D. Sardar, MD.
| Male | |
|---|---|
| Female |
| From 65 to 74 | |
|---|---|
| From 75 to 84 | |
| 85 and over | |
| Less than 65 |
(No ratings)
Dr. Philip D. Sardar, MD is a medical oncologist in Folsom, CA specializing in medical oncology, adult oncology and adult hematology. He graduated from King Edward Medical University. Dr. Philip D. Sardar, MD is affiliated with Dignity Health, Sutter Health, Hill Physicians and HEMATOLOGY AND ONCOLOGY ASSOCIATES OF NORTHERN CALIFORNIA.
Information about Medicare patients treated by Dr. Philip D. Sardar, MD.
| Male | 12 |
|---|---|
| Female | 11 |
| From 65 to 74 | 0 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 11 |
Information about Medicare patients treated by Dr. Philip D. Sardar, MD.
| From 65 to 74 | 12 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Philip D. Sardar, MD treated during 2022 were cancer and hypertension.
| Hypertension | 57 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 57 |
Information about Medicare patients treated by Dr. Philip D. Sardar, MD.
| Male | 11 |
|---|---|
| Female | 15 |
| From 65 to 74 | 12 |
|---|---|
| From 75 to 84 | 0 |
| 85 and over | 0 |
| Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Philip D. Sardar, MD treated during 2023 were hypertension.
| Hypertension | 42 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoperosis | 0 |
| Atrial Fibrilation | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Dementia | 0 |
| Cancer | 0 |
Information about Medicare patients treated by Dr. Philip D. Sardar, MD.
| Male | 7 |
|---|---|
| Female | 8 |
| 75 to 84 | 0 |
|---|---|
| 85 and over | 0 |
| Less than 65 | 3 |
| 65 to 74 | 8 |
The highest averages of the most common conditions of Medicare patients that Dr. Philip D. Sardar, MD treated were hypertension and cancer.
| Hypertension | 33 |
|---|---|
| High Cholesterol | 0 |
| Stroke | 0 |
| Ischemic Heart Disease | 0 |
| Depression | 0 |
| Chronic Kidney Disease | 0 |
| Asthma | 0 |
| Osteoporosis | 0 |
| Heart Failure | 0 |
| Chronic Obstructive Pulmonary Disease | 0 |
| Diabetes | 0 |
| Atrial Fibrillation | 0 |
| Cancer | 19 |
| Dementia | 0 |
Dr. Philip D. Sardar, MD graduated from King Edward Medical University. He completed residency at Methodist Hospital. He is certified by the Board Certification: Hematology and has a state license in California.
Medical School: King Edward Medical University
Residency: Methodist Hospital
Board Certification: Board Certification: Hematology
Licensed In: California
Dr. Philip D. Sardar, MD is associated with these hospitals and organizations:
Dr. Philip D. Sardar, MD appears to accept the following insurance providers: Cigna, AARP, Anthem Blue Cross of California, Blue Shield of California, WellCare, Health Net Medicare Advantage HMO, Medicare Advantage, United Healthcare, Accepted Aetna Plans: Health Fund HMO (aka HMO/HRA): HMO: HMO Deductible Plans: Quality Point of Service (QPOS), Accepted SCAN Plans: Sutter Senior Advantage, a SCAN Medicare Plan (HMO) and Accepted Sutter Health Plan Plans: Individual and Family Plan HMO: Large and Small Group HMO.
According to our sources, Dr. Philip D. Sardar, MD accepts the following insurance providers:
Dr. Philip D. Sardar, MD does not have any reviews yet, be the first to leave a review of Dr. Philip D. Sardar, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Philip D. Sardar, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Genentech USA, Inc. |
$378
TECENTRIQ $254 |
TARCEVA $125 |
||||
|---|---|---|---|---|---|---|
| Incyte Corporation |
$376
JAKAFI $376 |
|||||
| Alexion Pharmaceuticals, Inc. |
$239
SOLIRIS $239 |
|||||
| Clovis Oncology, Inc. |
$238
Rubraca $238 |
|||||
| Pfizer Inc. |
$218
IBRANCE $92 |
XTANDI $74 |
TUKYSA $33 |
ADCETRIS $19 |
||
| Other |
$1,690
XTANDI $196 |
ELITEK $119 |
Abraxane $117 |
IMBRUVICA $116 |
PADCEV $112 |
Other $1,030 |
| Food and Beverage | $3,139 |
|---|
Dr. Philip Sardar's medical specialty is adult hematology, adult oncology, and medical oncology. His professional affiliations include Dignity Health, Hill Physicians, and Sutter Health. Dr. Sardar appears to be an in-network provider for AARP, Anthem, and Blue California, in addition to other insurance carriers. His practice in Folsom, CA is open to new patients as reported by Hill Physicians. He is a graduate of King Edward Medical University. For his residency, Dr. Sardar trained at Methodist Healthcare, Memphis and Methodist Hospital. In addition to English, Dr. Sardar (or staff) speaks Hindi.